Skip to main content

Ransomware victim disclosure

← All victims

Novo Nordisk A/S

listed as Forma Therapeutics Holdings, Inc. · Claimed by Nightspire · listed 4 hours ago

Today
Age
since listed · data leaked

Status timeline

  1. ListedOct 3, 2026
  2. Data leakeddate unknown

At a glance

Status
Data leaked
Listed on leak site
Oct 3, 2026

About the victim

AI dossier — public-source company profile

Novo Nordisk is a multinational pharmaceutical company headquartered in Denmark, specializing in diabetes care, obesity treatment, and biologics. The company develops and markets prescription medicines including Wegovy® and operates a substantial R&D pipeline for clinical drug discovery and development.

Industry
Pharmaceutical & Biotechnology
Address
Novo Alle 1, 2880 Bagsværd, Denmark
Employees
48000
Founded
1923

Attack summary

Severity: critical — Confirmed exfiltration of regulated clinical trial data, drug discovery IP, and genomic research—highly sensitive pharmaceutical R&D materials subject to FDA oversight and international regulatory frameworks. Clinical and genomic data constitute PII at scale in healthcare context.

The nightspire group claims to have exfiltrated clinical trial data, statistical research information, electronic lab notebooks, research intellectual property, drug discovery pipeline data, and biological/genomic research from Forma Therapeutics Holdings, Inc. The leak post lists sensitive R&D materials but does not specify ransom demands.

critical

Data the group says was taken

AI dossier — extracted from the leak post
  • Clinical trial data
  • Statistical analysis data
  • Electronic lab notebooks
  • Research intellectual property
  • Drug discovery pipeline information
  • Biological research data
  • Genomic data

What the group claims

- Clinical Trial & Statistical Data- Electronic Lab Notebooks & Research IP- Drug Discovery & Pipeline Data- Biological Research & Genomic Data

Sources

Source

Indexed 4 hours ago

This page surfaces a public ransomware disclosure indexed by Darkfield. Original posts come from the operator's own leak site; we cross-check against ransomware.live, RansomLook and RansomWatch where applicable. Share this URL freely.

Is this your supplier? Your competitor? You?

Pro plans monitor your domain, corporate emails, and crypto wallets across every new ransomware leak-site post, breach dump and Telegram callout — alerts within 5 minutes.

Disclosure context

About nightspire

Nightspire is a ransomware group that first emerged in March 2025 and appears to be primarily financially motivated, having targeted over 215 victims in a relatively short operational timeframe. The group's origin and affiliations remain unclear due to limited public documentation from major cybersecurity organizations, though their targeting patterns suggest a broad opportunistic approach rather than nation-state backing. Based on available victim data, Nightspire appears to employ common ransomware attack vectors targeting organizations across multiple sectors, with a particular focus on manufacturing, technology, healthcare, and construction industries, while demonstrating a geographic preference for victims in the United States, India, Taiwan, France, and Hong Kong. The group's rapid victim acquisition rate since their March 2025 emergence suggests an active and potentially effective operational capability, though specific technical details about their attack methodology, encryption techniques, or extortion tactics have not been publicly documented by major threat intelligence firms. Given the recent emergence of this group and limited public reporting from established cybersecurity organizations like CISA, FBI, or Mandiant, Nightspire remains an active threat with insufficient public documentation to fully assess their operational sophistication or organizational structure. The group has been linked to 348 public disclosures across our corpus. First observed on a leak site on March 12, 2025; most recent post October 3, 2026. The operation is currently active.

Also tracked as: NIGHT SPIRE.

Timeline of this disclosure

  • October 3, 2026Forma Therapeutics Holdings, Inc. listed by nightspire on the group's public leak site

Sector and geography

This disclosure adds to ransomware activity in the Healthcare sector, which has 2,608 disclosures indexed across all operators we track. Geographically, Forma Therapeutics Holdings, Inc. is reported in United States, a country with 3,167 ransomware disclosures in our corpus.

If your organisation is affected

A listing by nightspire means Forma Therapeutics Holdings, Inc. appeared on a ransomware extortion site and data attributed to it has been published. If this is your organisation, or a supplier you depend on, the priority is to confirm the intrusion and contain it before the window to act closes.

  • Engage your incident-response team and preserve forensic evidence before remediating — do not wipe affected systems first.
  • Force a password reset and revoke active sessions for exposed accounts; rotate any credentials, API keys or certificates that may have been in the stolen data.
  • Assess regulatory notification duties (GDPR, NIS2, sector regulators) — many carry a 72-hour reporting clock from awareness.
  • Report the incident to your national CERT, CISA (United States), as required for your jurisdiction.
  • Monitor for the data appearing on nightspire's leak site and across paste and breach channels, and brief downstream partners who may be exposed through you.

How we know this. Darkfield monitors public ransomware leak sites continuously, archiving every new disclosure and the data later released against the victim. Each entry on this page is sourced from the operator's own publication and cross-checked against complementary OSINT feeds (RansomLook, ransomware.live, RansomWatch). We do not collect or host stolen data — only the metadata, timestamps and screenshots needed to make the public disclosure searchable and accountable. Records here are corrected when the original post is edited, retracted, or merged with another disclosure.